Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Galluccio

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Physical Review Letters|September 16, 2000
New algorithm for the Ising problem: partition function for finite lattice graphsA Galluccio, M Loebl, J Vondrák
Physical Review Letters|April 20, 2004
Critical thermodynamics of the two-dimensional +/-J Ising spin glassJ Lukic, A Galluccio, E Marinari, et al.
International Journal of Immunopathology and Pharmacology|March 30, 2006
Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study)N Cassano, F Loconsole, A Galluccio, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patientsN Cassano, A Puglisi Guerra, C Malara, et al.
Australian Dental Journal|May 29, 2009
The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case reportL Lamazza, F Guerra, M Pezza, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study GroupN Cassano, F Loconsole, A Miracapillo, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2009
The safety of anti-TNF agents in the elderlyA Migliore, E Bizzi, B Laganà, et al.
Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Physical Review Letters|September 16, 2000
New algorithm for the Ising problem: partition function for finite lattice graphsA Galluccio, M Loebl, J Vondrák
Physical Review Letters|April 20, 2004
Critical thermodynamics of the two-dimensional +/-J Ising spin glassJ Lukic, A Galluccio, E Marinari, et al.
International Journal of Immunopathology and Pharmacology|March 30, 2006
Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study)N Cassano, F Loconsole, A Galluccio, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patientsN Cassano, A Puglisi Guerra, C Malara, et al.
Australian Dental Journal|May 29, 2009
The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case reportL Lamazza, F Guerra, M Pezza, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study GroupN Cassano, F Loconsole, A Miracapillo, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2009
The safety of anti-TNF agents in the elderlyA Migliore, E Bizzi, B Laganà, et al.
Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.
Pageof 1